Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients (Q44421237)
Jump to navigation
Jump to search
scientific article published on January 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients |
scientific article published on January 1, 2003 |
Statements
1 reference
Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients (English)
1 reference
1 reference
Sumiyo Watanabe
1 reference
Yasuhiro Takeuchi
1 reference
Hiroko Fujita
1 reference
Tadasumi Nakano
1 reference
Toshiro Fujita
1 reference
1 January 2003
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference